Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours
Authors:
- 19 April 2019
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 143 (2) , 187-196
Abstract
Tumour-associated angiogenesis is associated with the malignancy and poor prognosis of glioma. Isocitrate dehydrogenase (IDH) mutations are present in the majority of lower-grade (WHO grade II and III) and secondary glioblastomas, but their roles in tumour angiogenesis remain unclear.Keywords
Funding Information
- National Natural Science Foundation of China (81572471, 81772659)
- National Natural Science Foundation of China (81372457, 81372457)
- National Natural Science Foundation of China (31671416)
- State Key Laboratory of Cancer Biolog (CBSKL2015Z11)
- the Booster Program of Xijing Hospital (XJZT15ZL03)
This publication has 40 references indexed in Scilit:
- Hyperplasia of Pericytes Is One of the Main Characteristics of Microvascular Architecture in Malignant GliomaPLOS ONE, 2014
- IDH1 and IDH2 Mutations in GliomasCurrent Neurology and Neuroscience Reports, 2013
- Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor GrowthCell, 2013
- D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane functionGenes & Development, 2012
- Central nervous system pericytes in health and diseaseNature Neuroscience, 2011
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationCancer Cell, 2010
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomasNeuro-Oncology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- Angiogenesis in brain tumoursNature Reviews Neuroscience, 2007
- The role of pericytes in blood-vessel formation and maintenanceNeuro-Oncology, 2005